Matrix metalloproteinase-13 is required for osteocytic perilacunar remodeling and maintains bone fracture resistance

Journal of Bone and Mineral Research

Volumn 27, Issue 9, 2012, Pages 1936-1950

  Tang, Simon Y ^a   Herber, Ralf Peter ^b   Ho, Sunita P ^b   Alliston, Tamara ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BONE MATRIX; BONE QUALITY; FRACTURE RESISTANCE; MATRIX METALLOPROTEINASE 13; OSTEOCYTE; OSTEOCYTE PERILACUNAR REMODELING; REMODELING

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLLAGEN; COLLAGENASE 3; SCLEROSTIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MATRIX; BONE MINERALIZATION; CELL FUNCTION; CONTROLLED STUDY; CORTICAL BONE; CROSS LINKING; DIAPHYSIS; ENZYME DEFICIENCY; FEMALE; FEMUR; FRACTURE; HISTOPATHOLOGY; LACTATION; MALE; MORPHOMETRICS; MOUSE; MUSCULOSKELETAL FUNCTION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOCYTE PERILACUNAR REMODELING; OSTEOLYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TIBIA; WILD TYPE;

ANIMALS; BIOMECHANICS; BONE MATRIX; BONE REMODELING; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; COLLAGEN; FEMALE; FRACTURES, BONE; LACTATION; MATRIX METALLOPROTEINASE 13; MICE; ORGAN SIZE; OSTEOBLASTS; OSTEOCLASTS; OSTEOCYTES; OSTEOGENESIS; PROTEIN TRANSPORT; TIBIA; X-RAY MICROTOMOGRAPHY;

EID: 84865237162     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1646     Document Type: Article

References (69)

1. Hernandez CJ, Keaveny TM,. A biomechanical perspective on bone quality. Bone. 2006; 39: 1173-81. (Pubitemid 44827914)
2. Faulkner KG, Cummings SR, Black D, Palermo L, Glüer CC, Genant HK,. Simple measurement of femoral geometry predicts hip fracture: The Study of Osteoporotic Fractures. J Bone Miner Res. 1993; 8: 1211-7. (Pubitemid 23308114)
3. Beck TJ, Ruff CB, Bissessur K,. Age-related changes in female femoral geometry: implications for bone strength. Calcif Tissue Int. 1993; 53: S41-6. (Pubitemid 23277167)
4. Vashishth D, Behiri JC, Bonfield W,. Crack growth resistance in cortical bone: concept of microcrack toughening. J Biomech. 1997; 30: 763-9. (Pubitemid 27309599)
5. Diab T, Vashishth D,. Effects of damage morphology on cortical bone fragility. Bone. 2005; 37: 96-102. (Pubitemid 40848422)
6. Burghardt AJ, Kazakia GJ, Ramachandran S, Link TM, Majumdar S,. Age and gender related differences in the geometric properties and biomechanical significance of intra-cortical porosity in the distal radius and tibia. J Bone Miner Res. 2009; 25: 983-93.
7. Tang SY, Vashishth D,. The relative contributions of non-enzymatic glycation and cortical porosity on the fracture toughness of aging bone. J Biomech. 2011; 44: 330-6.
8. Silva MJ, Brodt MD, Fan Z, Rho J-Y,. Nanoindentation and whole-bone bending estimates of material properties in bones from the senescence accelerated mouse SAMP6. J Biomech. 2004; 37: 1639-46. (Pubitemid 39237576)
9. Balooch G, Balooch M, Nalla RK, Schilling S, Filvaroff EH, Marshall GW, Marshall SJ, Ritchie RO, Derynck R, Alliston T,. TGF-beta regulates the mechanical properties and composition of bone matrix. Proc Natl Acad Sci U S A. 2005; 102: 18813-8. (Pubitemid 43049527)
10. Vashishth D, Gibson GJ, Khoury JI, Schaffler MB, Kimura J, Fyhrie DP,. Influence of nonenzymatic glycation on biomechanical properties of cortical bone. Bone. 2001; 28: 195-201. (Pubitemid 32140975)
11. Wang X, Shen X, Li X, Agrawal CM,. Age-related changes in the collagen network and toughness of bone. Bone. 2002; 31: 1-7. (Pubitemid 34754417)
12. Zimmermann EA, Schaible E, Bale H, Barth HD, Tang SY, Reichert P, Busse B, Alliston T, Ager JW 3rd, Ritchie RO,. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci U S A. 2011; 108: 14416-21.
13. Boskey AL, DiCarlo E, Paschalis E, West P, Mendelsohn R,. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int. 2005; 16: 2031-8. (Pubitemid 41790924)
14. Li CY, Schaffler MB, Wolde-Semait HT, Hernandez CJ, Jepsen KJ,. Genetic background influences cortical bone response to ovariectomy. J Bone Miner Res. 2005; 20: 2150-8. (Pubitemid 41698778)
15. Mohammad KS, Chen CG, Balooch G, Stebbins E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH, Ionova-Martin SS, Bracey JW, Hogue WR, Wong DH, Ritchie RO, Suva LJ, Derynck R, Guise TA, Alliston T,. Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone. PLoS One. 2009; 4: e5275.
16. Lane NE, Yao W,. Glucocorticoid-induced bone fragility. Ann N Y Acad Sci. 2010; 1192: 81-3.
17. Currey JD,. The design of mineralised hard tissues for their mechanical functions. J Exp Biol. 1999; 202: 3285-94. (Pubitemid 30018434)
18. Chang JL, Brauer DS, Johnson J, Chen CG, Akil O, Balooch G, Humphrey MB, Chin EN, Porter AE, Butcher K, Ritchie RO, Schneider RA, Lalwani A, Derynck R, Marshall GW, Marshall SJ, Lustig L, Alliston T,. Tissue-specific calibration of extracellular matrix material properties by transforming growth factor-β and Runx2 in bone is required for hearing. EMBO Rep. 2010; 11: 765-71.
19. Tang SY, Zeenath U, Vashishth D,. Effects of non-enzymatic glycation on cancellous bone fragility. Bone. 2007; 40: 1144-51. (Pubitemid 46386561)
20. Burr DB, Martin RB, Schaffler MB, Radin EL,. Bone remodeling in response to in vivo fatigue microdamage. J Biomech. 1985; 18: 189-200. (Pubitemid 15112335)
21. Tang SY, Allen MR, Phipps R, Burr DB, Vashishth D,. Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate. Osteoporos Int. 2009; 20: 887-94.
22. Allen MR, Iwata K, Phipps R, Burr DB,. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate. Bone. 2006; 39: 872-9. (Pubitemid 44311727)
23. Lane NE, Yao W, Balooch M, Nalla RK, Balooch G, Habelitz S, Kinney JH, Bonewald LF,. Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice. J Bone Miner Res. 2006; 21: 466-76.
24. Rundhaug JE,. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005; 9: 267-85.
25. Krane SM, Inada M,. Matrix metalloproteinases and bone. Bone. 2008; 43: 7-18.
26. Holmbeck K, Bianco P, Pidoux I, Inoue S, Billinghurst RC, Wu W, Chrysovergis K, Yamada S, Birkedal-Hansen H, Poole AR,. The metalloproteinase MT1-MMP is required for normal development and maintenance of osteocyte processes in bone. J Cell Sci. 2005; 118: 147-56. (Pubitemid 40277113)
27. Inoue K, Mikuni-Takagaki Y, Oikawa K, Itoh T, Inada M, Noguchi T, Park JS, Onodera T, Krane SM, Noda M, Itohara S,. A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism. J Biol Chem. 2006; 281: 33814-24. (Pubitemid 46036758)
28. Nyman JS, Lynch CC, Perrien DS, Thiolloy S, O'Quinn EC, Patil CA, Bi X, Pharr GM, Mahadevan-Jansen A, Mundy GR,. Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone. J Bone Miner Res. 2011; 26: 1252-60.
29. Stickens D, Behonick DJ, Ortega N, Heyer B, Hartenstein B, Yu Y, Fosang AJ, Schorpp-Kistner M, Angel P, Werb Z,. Altered endochondral bone development in matrix metalloproteinase 13-deficient mice. Development. 2004; 131: 5883-95. (Pubitemid 40123905)
30. Inada M, Wang Y, Byrne MH, Rahman MU, Miyaura C, Lõpez-Otín C, Krane SM,. Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification. Proc Natl Acad Sci U S A. 2004; 101: 17192-7. (Pubitemid 39627796)
31. Nagase H, Woessner JF,. Matrix metalloproteinases. J Biol Chem. 1999; 274: 21491-4. (Pubitemid 129519680)
32. Kennedy AM, Inada M, Krane SM, Christie PT, Harding B, Lõpez-Otín C, Sánchez LM, Pannett AA, Dearlove A, Hartley C, Byrne MH, Reed AA, Nesbit MA, Whyte MP, Thakker RV,. MMP13 mutation causes spondyloepimetaphyseal dysplasia, Missouri type (SEMD(MO). J Clin Invest. 2005; 115: 2832-42. (Pubitemid 41434410)
33. Richardson DW, Dodge GR,. Dose-dependent effects of corticosteroids on the expression of matrix-related genes in normal and cytokine-treated articular chondrocytes. Inflamm Res. 2003; 52: 39-49. (Pubitemid 36228477)
34. Johansson N, Westermarck J, Leppä S, Häkkinen L, Koivisto L, Lõpez-Otín C, Peltonen J, Heino J, Kähäri VM,. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ. 1997; 8: 243-50. (Pubitemid 27068902)
35. Tardif G, Reboul P, Dupuis M, Geng C, Duval N, Pelletier JP, Martel-Pelletier J,. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. J Rheumatol. 2001; 28: 1631-9. (Pubitemid 32660638)
36. Selvamurugan N, Jefcoat SC, Kwok S, Kowalewski R, Tamasi JA, Partridge NC,. Overexpression of Runx2 directed by the matrix metalloproteinase-13 promoter containing the AP-1 and Runx/RD/Cbfa sites alters bone remodeling in vivo. J Cell Biochem. 2006; 99: 545-57. (Pubitemid 44435571)
37. Ortega N, Behonick DJ, Colnot C, Cooper DN, Werb Z,. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell. 2005; 16: 3028-39. (Pubitemid 40741245)
38. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR,. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987; 2: 595-610.
39. Sawyer A, Lott P, Titrud J, McDonald J,. Quantification of tartrate resistant acid phosphatase distribution in mouse tibiae using image analysis. Biotech Histochem. 2003; 78: 271-8. (Pubitemid 38208272)
40. Derkx P, Birkenhäger-Frenkel DH,. A thionin stain for visualizing bone cells, mineralizing fronts and cement lines in undecalcified bone sections. Biotech Histochem. 1995; 70: 70-4.
41. Allison RT,. Picro-thionin (Schmorl) staining of bone and other hard tissues. Br J Biomed Sci. 1995; 52: 162-4.
42. Woessner JF,. The determination of hydroxyproline in tissue and protein samples containing small proportions of this amino acid. Arch Biochem Biophys. 1961; 93: 440-7.
43. Garnero P, Delmas PD,. New developments in biochemical markers for osteoporosis. Calcif Tissue Int. 1996; 59 (Suppl 1): S2-9. (Pubitemid 26371195)
44. Lenora J, Ivaska KK, Obrant KJ, Gerdhem P,. Prediction of bone loss using biochemical markers of bone turnover. Osteoporos Int. 2007; 18: 1297-305. (Pubitemid 47300283)
45. Oliver W, Pharr G,. Measurement of hardness and elastic modulus by instrumented indentation: advances in understanding and refinements to methodology. J Mater Res. 2004; 19: 3-20.
46. Tang SY, Mathews P, Randall C, Yurtsev E, Fields K, Wong A, Kuo A, Alliston T, Hansma P,. In situ materials characterization using the tissue diagnostic instrument. Polym Test. 2010; 29: 159-63.
47. Jepsen KJ, Pennington DE, Lee YL, Warman M, Nadeau J,. Bone brittleness varies with genetic background in A/J and C57BL/6J inbred mice. J Bone Miner Res. 2001; 16: 1854-62. (Pubitemid 32911492)
48. Ritchie RO, Koester KJ, Ionova S, Yao W, Lane NE, Ager JW 3rd., Measurement of the toughness of bone: a tutorial with special reference to small animal studies. Bone. 2008; 43: 798-812.
49. Vashishth D,. Small animal bone biomechanics. Bone. 2008; 43: 794-7.
50. Behonick DJ, Xing Z, Lieu S, Buckley JM, Lotz JC, Marcucio RS, Werb Z, Miclau T, Colnot C,. Role of matrix metalloproteinase 13 in both endochondral and intramembranous ossification during skeletal regeneration. PLoS One. 2007; 2: e1150.
51. Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL,. Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem. 1997; 272: 22053-8. (Pubitemid 27382830)
52. Nakamura H, Sato G, Hirata A, Yamamoto T,. Immunolocalization of matrix metalloproteinase-13 on bone surface under osteoclasts in rat tibia. Bone. 2004; 34: 48-56. (Pubitemid 38142433)
53. Aarden EM, Burger EH, Nijweide PJ,. Function of osteocytes in bone. J Cell Biochem. 1994; 55: 287-99. (Pubitemid 24218803)
54. Bonewald L,. The amazing osteocyte. J Bone Miner Res. 2010; 26: 229-38.
55. Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jähn K, Kato S, Wysolmerski J, Bonewald LF,. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res. Epub 2012 Feb 3. DOI: 10.1002/jbmr.1567.
56. Kozloff KM, Carden A, Bergwitz C, Forlino A, Uveges TE, Morris MD, Marini JC, Goldstein SA,. Brittle IV mouse model for osteogenesis imperfecta IV demonstrates postpubertal adaptations to improve whole bone strength. J Bone Miner Res. 2004; 19: 614-22. (Pubitemid 41071222)
57. Ewart L, Suresh S,. Crack propagation in ceramics under cyclic loads. J Mater Sci. 1987; 22: 1173-92. (Pubitemid 17590363)
58. Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P,. Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci U S A. 2006; 103: 17741-6. (Pubitemid 44852230)
59. Vashishth D, Tanner KE, Bonfield W,. Fatigue of cortical bone under combined axial-torsional loading. J Orthop Res. 2001; 19: 414-20. (Pubitemid 32472011)
60. Hernandez CJ, Tang SY, Baumbach BM, Hwu PB, Sakkee AN, van der Ham F, DeGroot J, Bank RA, Keaveny TM,. Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links. Bone. 2005; 37: 825-32. (Pubitemid 41773493)
61. Tang SY, Vashishth D,. Non-enzymatic glycation alters microdamage formation in human cancellous bone. Bone. 2010; 46: 148-54.
62. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaissé JM,. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol. 2000; 151: 879-89.
63. Rasmussen P,. Calcium deficiency, pregnancy, and lactation in rats. Microscopic and microradiographic observations on bones. Calcif Tissue Res. 1977; 23: 95-102. (Pubitemid 8107550)
64. Wong KM, Singer L, Ophaug RH, Klein L,. Effect of lactation and calcium deficiency, and of fluoride intake, on bone turnover in rats: isotopic measurements of bone resorption and formation. J Nutr. 1981; 111: 1848-54. (Pubitemid 12209493)
65. Wong KM, Singer L, Ophaug RH,. Effect of lactation and/or calcium deficiency on cyclic-AMP production and bone enzyme activities in rats: lack of effect of long-term fluoride administration. Ann Nutr Metab. 1983; 27: 125-31. (Pubitemid 13080362)
66. Liu XS, Ardeshirpour L, VanHouten JN, Shane E, Wysolmerski JJ,. Site-specific changes in bone microstructure, mineralization, and stiffness during lactation and after weaning in mice. J Bone Miner Res. 2012 Apr; 27 (4): 865-75.
67. Haller AC, Zimny ML,. Effects of hibernation on interradicular alveolar bone. J Dent Res. 1977; 56: 1552-7.
68. Steinberg B, Singh IJ, Mitchell OG,. The effects of cold-stress. Hibernation, and prolonged inactivity on bone dynamics in the golden hamster, Mesocricetus auratus. J Morphol. 1981; 167: 43-51.
69. Harvey KB, Donahue SW,. Bending properties, porosity, and ash fraction of black bear (Ursus americanus) cortical bone are not compromised with aging despite annual periods of disuse. J Biomech. 2004; 37: 1513-20. (Pubitemid 39141844)